Privia Health Group, Inc.

Privia Health Group, Inc. reported strong financial results for the second quarter and first six months of 2026. Revenue for Q2 increased by 21.4% to $632.6 million, while net income attributable to the company surged by 236.7% to $9.0 million, resulting in diluted EPS of $0.07. The company also expanded its operations by acquiring a 77% ownership interest in PMG-NJ in the New Jersey market for $11.43 million in cash, bringing its total market presence to 17.

Privia Health Group, Inc. announced strong financial results for the second quarter ended June 30, 2026, with net income surging 236.7% to $9.0 million and Adjusted EBITDA increasing 29.1% to $37.4 million. Total revenue for the quarter rose 21.4% to $632.6 million. Following this performance, the company raised its full-year 2026 guidance for all key financial metrics, including Attributed Lives and Adjusted EBITDA.

Privia Health Group, Inc. announced strong financial results for the second quarter and six-month periods ended June 30, 2026, and raised its full-year 2026 guidance for all key financial metrics. The company reported a significant increase in Q2'26 Net Income by 236.7% to $9.0 million and Adjusted EBITDA by 29.1% to $37.4 million. Total revenue for the quarter grew 21.4% to $632.6 million, driven by growth in implemented providers and attributed lives. The updated guidance reflects continued operational strength and positive outlook for the remainder of the year.

Privia Health Group, Inc. announced that Shawn Morris resigned from his position as a member of the Board of Directors and the Compliance Committee, effective July 6, 2026. The company stated that his resignation was not due to any disagreement with its operations, policies, or practices. Privia Health expressed sincere gratitude for Mr. Morris's dedicated service and contributions during his tenure.

Privia Health Group, Inc. announced a definitive agreement to expand into New Jersey through a partnership with Neurology Group of Bergen County (NGBC). NGBC, a practice with 25 clinicians, will serve as the anchor for Privia Medical Group—New Jersey, with implementation expected by year-end 2026. This expansion leverages Privia's platform and expertise to support community clinicians and enhance patient care across various reimbursement models in the state. The partnership aims to expand access to high-quality neurological care while maintaining NGBC's independent culture.

Privia Health Group, Inc. reported a significant 26% increase in revenue, reaching $603.8 million for the first quarter of 2026, alongside a 42% rise in operating income to $7.4 million. However, net income attributable to Privia Health Group, Inc. decreased by 27% to $3.1 million, primarily impacted by a higher effective tax rate and increased stock-based compensation. The company also saw an increase in net cash used in operating activities and expanded its operations into new geographic markets.

Privia Health Group, Inc. announced strong financial results for the first quarter ended March 31, 2026, with total revenue increasing by 25.8% to $603.8 million and Adjusted EBITDA growing by 36.3% to $36.7 million. The company also reported significant growth in key operating metrics, including a 13.6% rise in Implemented Providers and a 26.5% increase in Value-Based Care Attributed Lives. Privia Health reiterated its full-year 2026 guidance for most metrics while raising its outlook for Attributed Lives, reflecting continued momentum.

Privia Health Group, Inc. announced strong financial results for the first quarter ended March 31, 2026. The company reported a 25.8% increase in total revenue to $603.8 million and a 22.3% rise in non-GAAP adjusted net income to $24.3 million. Adjusted EBITDA also saw significant growth, up 36.3% to $36.7 million. Privia Health reiterated its full-year 2026 guidance for most metrics and raised its outlook for Attributed Lives, reflecting continued momentum.